Latest News about Briefs
Recent news which mentions Briefs
Martin Marietta Faces Headwinds: Q3 Revenue Declines Amid Severe Weather Impacts, Revises Outlook
October 30, 2024
From Benzinga
Humana Lifts 2024 Profit Outlook As Q3 Earnings Beat Street View On Medicare Strength
October 30, 2024
From Benzinga
Kraft Heinz Q3 Results: Earnings Beat, Revenue Dips, Sees 'Elongated Recovery' Across US Retail Business
October 30, 2024
From Benzinga
ADP Raises The Bar After Q1 Earnings Surprise
October 30, 2024
From Benzinga
Garmin Q3 Earnings: Strong Revenue Growth Wearable Demand, Margin Expansion, Holiday Season Prompts Outlook Boost
October 30, 2024
From Benzinga
Bunge Beats On Q3 Earnings, Agribusiness Weighs On Growth Amid Global Margin Pressure
October 30, 2024
From Benzinga
Semiconductor Company UMC Surpasses Q3 Revenue Expectations, Eyes Growth With New Projects In Pipeline
October 30, 2024
From Benzinga
Brinker Surges On Q1 Beat, Chili's Drives Big Gains
October 30, 2024
From Benzinga
Caterpillar Q3 Earnings: Revenue Falls Short Of Expectations, CEO Anticipates Muted China Demand
October 30, 2024
From Benzinga
GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024
October 30, 2024
From Benzinga
From Benzinga
Electronic Arts Q2 Earnings: EPS Beat, Solid Bookings, Football's $1 Billion Run In Sight & More
October 30, 2024
From Benzinga
Eli Lilly Q3 Earnings: Mounjaro Sales More Than Double, Takes $2.98 Billion Hit To Profit, Cuts Annual Outlook, Stock Tanks
October 30, 2024
From Benzinga
Asia Ex-Japan And Europe Markets Dip; Gold Clocks New High, Dollar Softens - Global Markets Today While US Slept
October 30, 2024
From Benzinga
Analysts Highlight V.F. Corp's Margin Gains And Sales Momentum, Remain Cautious On Valuation Potential
October 29, 2024
From Benzinga
OpenAI Chooses Broadcom For AI Interface Chip Development
October 29, 2024
From Benzinga
Coya Therapeutics' High-Dose Interleukin-2 Misses The Mark In Mid-Stage Alzheimer's Study
October 29, 2024
From Benzinga
From Benzinga
Royal Caribbean's Q3 EPS Beats, But Goldman Sachs Cautions On Rising Q4 Costs And EPS Impact
October 29, 2024
From Benzinga
Organ Transplant MedTech TransMedics Q3 Performance Disappoints, Analyst Outlines Investor Worries
October 29, 2024
From Benzinga
From Benzinga
Salesforce Launches Agentforce, Redefining AI In Business With Autonomous Solutions
October 29, 2024
From Benzinga
Schlumberger's OneSubsea Lands Key Contract With BP To Power Deepwater Kaskida Project: Details
October 29, 2024
From Benzinga
What's Going On With Trump Media & Technology Stock On Tuesday?
October 29, 2024
From Benzinga
Penske Automotive Group Stock Dips After Q3 Earnings Miss Amid Continued Freight Challenges
October 29, 2024
From Benzinga
From Benzinga
From Benzinga
PayPal's Solid Transaction Growth Boosts JP Morgan's Confidence, Yet Q4 Revenue Guidance Dampens Enthusiasm: Analyst
October 29, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
